APP and Alzheimer disease: In the present study, the pharmacological effects of brexpiprazole on BPSD‐like symptoms in Alzheimer's dementia models were evaluated, using resident intruder model in Tg2576 mice and the circadian rhythm alterations model in APPSL‐Tg mice23, 24 overexpressing a mutant form of APP with the Swedish and London mutations.